Maxime Melikian

449 total citations
11 papers, 370 citations indexed

About

Maxime Melikian is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Maxime Melikian has authored 11 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Maxime Melikian's work include Protease and Inhibitor Mechanisms (5 papers), Peptidase Inhibition and Analysis (4 papers) and Signaling Pathways in Disease (3 papers). Maxime Melikian is often cited by papers focused on Protease and Inhibitor Mechanisms (5 papers), Peptidase Inhibition and Analysis (4 papers) and Signaling Pathways in Disease (3 papers). Maxime Melikian collaborates with scholars based in Italy, United States and Germany. Maxime Melikian's co-authors include Marco Fragai, Claudio Luchinat, Ivano Bertini, Dmitri I. Svergun, Efstratios Mylonas, V. Calderone, Gregg B. Fields, Janelle Lauer, Johannes Gramüller and Johnny Hioe and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Maxime Melikian

11 papers receiving 369 citations

Peers

Countries citing papers authored by Maxime Melikian

Since Specialization

Citations

This map shows the geographic impact of Maxime Melikian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Melikian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Melikian more than expected).

Fields of papers citing papers by Maxime Melikian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxime Melikian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Melikian. The network helps show where Maxime Melikian may publish in the future.

Co-authorship network of co-authors of Maxime Melikian

This figure shows the co-authorship network connecting the top 25 collaborators of Maxime Melikian. A scholar is included among the top collaborators of Maxime Melikian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxime Melikian. Maxime Melikian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Brønsted acid catalysis – the effect of 3,3′-substituents on the structural space and the stabilization of imine/phosphoric acid complexes 2019 ·Chemical Science ·Maxime Melikian, Johannes Gramüller, Johnny Hioe, (unknown), Ruth M. Gschwind	25
2	Internal acidity scale and reactivity evaluation of chiral phosphoric acids with different 3,3′-substituents in Brønsted acid catalysis 2019 ·Chemical Science ·(unknown), Maxime Melikian, Johnny Hioe, (unknown), Johannes Gramüller, (unknown), (unknown), Thomas Häusler, (unknown), Ruth M. Gschwind	31
3	Model of the Interaction between the NF-κB Inhibitory Protein p100 and the E3 Ubiquitin Ligase β-TrCP based on NMR and Docking Experiments 2016 ·Journal of Chemical Information and Modeling ·Maxime Melikian, (unknown), Gildas Bertho, Véronique Baud, Nathalie Evrard‐Todeschi	8
4	Interaction of a small molecule Natura-α and STAT3-SH2 domain to block Y705 phosphorylation and inhibit lupus nephritis 2015 ·Biochemical Pharmacology ·Jen Wei Chiao, Maxime Melikian, Liying Han, Chengsen Xue, (unknown), Luxi Wang, (unknown), John T. Fallon, Karim Solangi, Gildas Bertho, (unknown), (unknown)	6
5	Synthesis of New Steroidal Inhibitors of P-Glycoprotein-Mediated Multidrug Resistance and Biological Evaluation on K562/R7 Erythroleukemia Cells 2015 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Maxime Melikian, Zahia Mahiout, Agnès Emptoz-Bonneton, Eva‐Laure Matera, Thierry Lomberget, Roland Barret, (unknown), Nadia Walchshofer, (unknown), (unknown), (unknown), Catherine Grenot, Michel Pugeat, Charles Dumontet, Marc Le Borgne, (unknown)	12
6	Unraveling Hidden Regulatory Sites in Structurally Homologous Metalloproteases 2013 ·Journal of Molecular Biology ·Yael Udi, Marco Fragai, Moran Grossman, Simon Mitternacht, Rina Arad‐Yellin, V. Calderone, Maxime Melikian, (unknown), Igor N. Berezovsky, Claudio Luchinat, Irit Sagi	50
7	Structural Basis for Matrix Metalloproteinase 1-Catalyzed Collagenolysis 2011 ·Journal of the American Chemical Society ·Ivano Bertini, Marco Fragai, Claudio Luchinat, Maxime Melikian, (unknown), Janelle Lauer, Gregg B. Fields	93
8	Characterisation of the MMP‐12–Elastin Adduct 2009 ·Chemistry - A European Journal ·Ivano Bertini, Marco Fragai, Claudio Luchinat, Maxime Melikian, Chiara Venturi	12
9	Interdomain Flexibility in Full-length Matrix Metalloproteinase-1 (MMP-1) 2009 ·Journal of Biological Chemistry ·Ivano Bertini, Marco Fragai, Claudio Luchinat, Maxime Melikian, Efstratios Mylonas, (unknown), Dmitri I. Svergun	60
10	Evidence of Reciprocal Reorientation of the Catalytic and Hemopexin-Like Domains of Full-Length MMP-12 2008 ·Journal of the American Chemical Society ·Ivano Bertini, V. Calderone, Marco Fragai, (unknown), Claudio Luchinat, Maxime Melikian, Efstratios Mylonas, Dmitri I. Svergun	72
11	Magnetic Properties of Model Multicomponent Compounds of CsCl Structure 1989 ·physica status solidi (b) ·(unknown), (unknown), (unknown), Armen Kocharian, Maxime Melikian, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact